<DOC>
	<DOC>NCT02309736</DOC>
	<brief_summary>This is a prospective multicenter observational single arm post-approval registry that will collect post-approval data relative to the incidence of endophthalmitis for cataract surgery patients treated with the FDA-approved ReSure Sealant when used by a broad group of physicians under commercial use conditions.</brief_summary>
	<brief_title>ReSure Sealant Device Exposure Registry</brief_title>
	<detailed_description />
	<mesh_term>Endophthalmitis</mesh_term>
	<criteria>Received at least one application of the ReSure Sealant on the operative eye following cataract surgery</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>